Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

15 April 2026 : Clinical Research  

Phospho-Histone H3 as a Tool for Improved Mitotic Counting and Risk Assessment in Gastrointestinal Stromal Tumors: A Study of 241 Cases

Xu Liu ORCID logo ADE 1,2, Jiao Liu BC 3, Yahui Cui CF 4, Hanhan Lei CD 1,2, Yuchang Hu DG 1,2, Yufei Liu DG 1,2*

DOI: 10.12659/MSM.952182

Med Sci Monit 2026; 32:e952182

Table 3 Comparison of RS based on MC-HE and MC-PHH3.

CaseSex/ageTumor siteMC-HE (5 mm2/21HPF)RSMC-PHH3 (5 mm2/21HPF)RS
1Male/64yStomach4Low8Medium
2Female/58yStomach2Low6Medium
3Male/53yStomach9Medium12High
4Male/53yStomach9Medium15High
5Female/42ySmall intestine3Very low6Medium
6Male/53ySmall intestine6Medium11High
7Female/62ySmall intestine8Medium14High
8Female/48yLarge intestine7Medium12High
9Female/63yStomach12High8Medium
10Male/61yStomach11High9Medium
11Male/50yStomach7Medium4Low
12Female/45ySmall intestine10High4Low
RS – risk stratification; MC-HE – mitotic count on hematoxylin-eosin; MC-PHH3 – mitotic count on phospho-histone H3; HPF – high-power field.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750